Eric L. Reyner

1.6k total citations
23 papers, 1.1k citations indexed

About

Eric L. Reyner is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Eric L. Reyner has authored 23 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 12 papers in Oncology and 4 papers in Organic Chemistry. Recurrent topics in Eric L. Reyner's work include Drug Transport and Resistance Mechanisms (8 papers), Pharmacological Effects and Toxicity Studies (4 papers) and Nitric Oxide and Endothelin Effects (3 papers). Eric L. Reyner is often cited by papers focused on Drug Transport and Resistance Mechanisms (8 papers), Pharmacological Effects and Toxicity Studies (4 papers) and Nitric Oxide and Endothelin Effects (3 papers). Eric L. Reyner collaborates with scholars based in United States, United Kingdom and Belgium. Eric L. Reyner's co-authors include Barbra H. Stewart, O. Helen Chan, Caroline A. Lee, Rebecca A. Boyd, Lloyd R. Whitfield, Edward J. Randinitis, Jeff B. Smaill, Gordon W. Rewcastle, William A. Denny and Elke Lipka and has published in prestigious journals such as Journal of the American Chemical Society, Nucleic Acids Research and Biochemical and Biophysical Research Communications.

In The Last Decade

Eric L. Reyner

23 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Eric L. Reyner United States	15	495	419	229	177	177	23	1.1k
Matthew Wright United States	25	352 0.7×	472 1.1×	342 1.5×	140 0.8×	284 1.6×	85	1.8k
William J. Ehlhardt United States	15	469 0.9×	426 1.0×	195 0.9×	170 1.0×	235 1.3×	31	1.1k
Lanyan Fang United States	17	349 0.7×	593 1.4×	246 1.1×	140 0.8×	132 0.7×	68	1.4k
Alain Deroussent France	21	402 0.8×	529 1.3×	140 0.6×	125 0.7×	149 0.8×	47	1.5k
Satoru Asahi Japan	16	449 0.9×	382 0.9×	100 0.4×	188 1.1×	455 2.6×	52	1.3k
Edna F. Choo United States	24	797 1.6×	1.0k 2.4×	151 0.7×	281 1.6×	286 1.6×	54	1.9k
A. Bernareggi United States	22	432 0.9×	399 1.0×	142 0.6×	91 0.5×	131 0.7×	63	1.3k
Mark A. Winter United States	13	694 1.4×	411 1.0×	197 0.9×	192 1.1×	148 0.8×	15	1.2k
David D. Christ United States	25	335 0.7×	537 1.3×	401 1.8×	86 0.5×	472 2.7×	49	1.9k
Vijay Upreti United States	20	491 1.0×	403 1.0×	68 0.3×	206 1.2×	328 1.9×	55	1.7k

Countries citing papers authored by Eric L. Reyner

Since Specialization

Citations

This map shows the geographic impact of Eric L. Reyner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric L. Reyner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric L. Reyner more than expected).

Fields of papers citing papers by Eric L. Reyner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric L. Reyner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric L. Reyner. The network helps show where Eric L. Reyner may publish in the future.

Co-authorship network of co-authors of Eric L. Reyner

This figure shows the co-authorship network connecting the top 25 collaborators of Eric L. Reyner. A scholar is included among the top collaborators of Eric L. Reyner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eric L. Reyner. Eric L. Reyner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Abramson, Vandana G., Mafalda Oliveira, Andrés Cervantes, et al.. (2019). A phase Ib, open-label, dose-escalation study of the safety and pharmacology of taselisib (GDC-0032) in combination with either docetaxel or paclitaxel in patients with HER2-negative, locally advanced, or metastatic breast cancer. Breast Cancer Research and Treatment. 178(1). 121–133. 4 indexed citations

Reyner, Eric L., Mark A. West, Katherine S. Fenner, et al.. (2013). In Vitro Characterization of Axitinib Interactions with Human Efflux and Hepatic Uptake Transporters: Implications for Disposition and Drug Interactions. Drug Metabolism and Disposition. 41(8). 1575–1583. 32 indexed citations

Di, Li, John P. Umland, Hui Zhang, et al.. (2011). Development of a new permeability assay using low‐efflux MDCKII cells. Journal of Pharmaceutical Sciences. 100(11). 4974–4985. 186 indexed citations

Taub, Mitchell E., Rucha Sane, Harma Ellens, et al.. (2011). Digoxin Is Not a Substrate for Organic Anion-Transporting Polypeptide Transporters OATP1A2, OATP1B1, OATP1B3, and OATP2B1 but Is a Substrate for a Sodium-Dependent Transporter Expressed in HEK293 Cells. Drug Metabolism and Disposition. 39(11). 2093–2102. 57 indexed citations

Lee, Caroline A., Jack Cook, Eric L. Reyner, & Dennis A. Smith. (2010). P-glycoprotein related drug interactions: clinical importance and a consideration of disease states. Expert Opinion on Drug Metabolism & Toxicology. 6(5). 603–619. 58 indexed citations

Vernier, William F., Wesley K. M. Chong, David A. Rewolinski, et al.. (2010). Thioether benzenesulfonamide inhibitors of carbonic anhydrases II and IV: Structure-based drug design, synthesis, and biological evaluation. Bioorganic & Medicinal Chemistry. 18(9). 3307–3319. 39 indexed citations

Calcagno, Anna Maria, Jennifer Fostel, Eric L. Reyner, et al.. (2004). Effects of An E-cadherin-Derived Peptide on the Gene Expression of Caco-2 Cells. Pharmaceutical Research. 21(11). 2085–2094. 3 indexed citations

Sahi, Jasminder, et al.. (2002). The Effect of Bergamottin on Diazepam Plasma Levels and P450 Enzymes in Beagle Dogs. Drug Metabolism and Disposition. 30(2). 135–140. 18 indexed citations

Smaill, Jeff B., Gordon W. Rewcastle, Joseph A. Loo, et al.. (2000). Tyrosine Kinase Inhibitors. 17. Irreversible Inhibitors of the Epidermal Growth Factor Receptor: 4-(Phenylamino)quinazoline- and 4-(Phenylamino)pyrido[3,2-d]pyrimidine-6-acrylamides Bearing Additional Solubilizing Functions. Journal of Medicinal Chemistry. 43(7). 1380–1397. 217 indexed citations

10.

Boyd, Rebecca A., R. H. Stern, Barbra H. Stewart, et al.. (2000). Atorvastatin Coadministration May Increase Digoxin Concentrations by Inhibition of Intestinal P-Glycoprotein-Mediated Secretion. The Journal of Clinical Pharmacology. 40(1). 91–98. 139 indexed citations

11.

Smaill, Jeff B., Gordon W. Rewcastle, Alexander J. Bridges, et al.. (2000). Tyrosine Kinase Inhibitors. 17. Irreversible Inhibitors of the Epidermal Growth Factor Receptor: 4-(Phenylamino)quinazoline- and 4-(Phenylamino)pyrido[3,2-d]pyrimidine-6-acrylamides Bearing Additional Solubilizing Functions.. Journal of Medicinal Chemistry. 43(16). 3199–3199. 12 indexed citations

12.

Boyd, Rebecca A., Ralph H. Stern, Xiaochun Wu, et al.. (2000). Atorvastatin Coadministration May Increase Digoxin Concentrations by Inhibition of Intestinal P‐Glycoprotein‐Mediated Secretion. The Journal of Clinical Pharmacology. 40(1). 91–98. 25 indexed citations

13.

Patt, William C., Joseph T. Repine, Annette M. Doherty, et al.. (1997). γ-Carbamate butenolide analogues as potent ETA selective endothelin receptor antagonists and prodrugs. Bioorganic & Medicinal Chemistry Letters. 7(3). 297–302. 3 indexed citations

14.

Stewart, Barbra H., Eric L. Reyner, Roger N. Hayes, et al.. (1996). In vitro assessment of oral delivery for hexapeptide endothelin antagonists. Life Sciences. 58(12). 971–982. 9 indexed citations

15.

Prasad, J. V. N. Vara, Peter J. Tummino, Donna Ferguson, et al.. (1996). Nonpeptidic HIV Protease Inhibitors: 4-Hydroxy-pyran-2-one Inhibitors with Functional Tethers to P1Phenyl Ring to Reach S3Pocket of the Enzyme. Biochemical and Biophysical Research Communications. 221(3). 815–820. 5 indexed citations

16.

Stewart, Barbra H., et al.. (1995). Comparison of Intestinal Permeabilities Determined in Multiple in Vitro and inSitu Models: Relationship to Absorption in Humans. Pharmaceutical Research. 12(5). 693–699. 149 indexed citations

17.

Prasad, J. V. N. Vara, Elizabeth A. Lunney, Donna Ferguson, et al.. (1995). HIV Protease Inhibitors Possessing a Novel, High-Affinity, and Achiral P1'/P2' Ligand with a Unique Pattern of in Vitro Resistance. Importance of a Conformationally-Restricted Template in the Design of Enzyme Inhibitors. Journal of the American Chemical Society. 117(45). 11070–11074. 25 indexed citations

18.

Gorski, Jerome L., Michael Boehnke, Eric L. Reyner, & Eric N. Burright. (1992). A radiation hybrid map of the proximal short arm of the human X chromosome spanning incontinentia pigmenti 1 (IP1) translocation breakpoints. Genomics. 14(3). 657–665. 16 indexed citations

19.

Gorski, Jerome L., Eric N. Burright, Eric L. Reyner, Peter N. Goodfellow, & Daniel L. Burgess. (1992). Isolation of DNA markers from a region between incontinentia pigmenti 1 (IP1) X-chromosomal translocation breakpoints by a comparative PCR analysis of a radiation hybrid subclone mapping panel. Genomics. 14(3). 649–656. 8 indexed citations

20.

Burright, Eric N., Eric L. Reyner, & Jerome L. Gorski. (1991). Human-specific amplification of radiation hybrid DNA fractionated by pulsed-field gel electrophoresis. Nucleic Acids Research. 19(2). 401–402. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact